Lataa...
Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
Design and development of an effective drug to combat the 2019 novel coronavirus remains a challenge. Therefore, it is of interest to study the binding features of 1615 FDA approved drugs with the recently known 2019-nCoV main protease structure having high sequence homology with that from SARS-CoV....
Tallennettuna:
| Julkaisussa: | Bioinformation |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Biomedical Informatics
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7147498/ https://ncbi.nlm.nih.gov/pubmed/32308266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630016236 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|